东南国防医药
東南國防醫藥
동남국방의약
JOURNAL OF SOUTHEAST CHINA NATIONAL DEFENCE MEDICAL SCIENCE
2014年
5期
479-481
,共3页
吴欣宇%韩玉惠%郑德泉%曾友福%董闽田%卢武生
吳訢宇%韓玉惠%鄭德泉%曾友福%董閩田%盧武生
오흔우%한옥혜%정덕천%증우복%동민전%로무생
鞘内注射%两性霉素B%伏立康唑%脑曲霉菌病
鞘內註射%兩性黴素B%伏立康唑%腦麯黴菌病
초내주사%량성매소B%복립강서%뇌곡매균병
intrathecal injection%amphotericin B%voriconazole%cerebral aspergillosis
目的:脑曲霉菌病的发病率日益增多,治疗药物有限,病死率很高。总结成功救治1例脑曲霉菌病患者的经验。方法立体定向下行脑穿刺活检术,脑组织病理活检结果明确诊断。治疗采用联合抗真菌治疗,伏立康唑0.2 g,2/d,静脉滴注,疗程70 d;间断小剂量鞘内注射两性霉素B,剂量0.1 mg,1/周。结果复查头颅磁共振,与初起病时比较病变明显吸收,临床症状好转。随访3年无复发。结论小剂量两性霉素B鞘内注射联合静脉滴注伏立康唑治疗脑曲霉菌病有较好疗效,无明显不良反应。
目的:腦麯黴菌病的髮病率日益增多,治療藥物有限,病死率很高。總結成功救治1例腦麯黴菌病患者的經驗。方法立體定嚮下行腦穿刺活檢術,腦組織病理活檢結果明確診斷。治療採用聯閤抗真菌治療,伏立康唑0.2 g,2/d,靜脈滴註,療程70 d;間斷小劑量鞘內註射兩性黴素B,劑量0.1 mg,1/週。結果複查頭顱磁共振,與初起病時比較病變明顯吸收,臨床癥狀好轉。隨訪3年無複髮。結論小劑量兩性黴素B鞘內註射聯閤靜脈滴註伏立康唑治療腦麯黴菌病有較好療效,無明顯不良反應。
목적:뇌곡매균병적발병솔일익증다,치료약물유한,병사솔흔고。총결성공구치1례뇌곡매균병환자적경험。방법입체정향하행뇌천자활검술,뇌조직병리활검결과명학진단。치료채용연합항진균치료,복립강서0.2 g,2/d,정맥적주,료정70 d;간단소제량초내주사량성매소B,제량0.1 mg,1/주。결과복사두로자공진,여초기병시비교병변명현흡수,림상증상호전。수방3년무복발。결론소제량량성매소B초내주사연합정맥적주복립강서치료뇌곡매균병유교호료효,무명현불량반응。
Objective Cerebral aspergillosis is increasing with more immunocompromised hosts.At present,the treatment of cerebral aspergillosis is limited,which has a high mortality rate.We treated of a cerebral aspergillosis patient successfully,and provided the clinical reference.Methods We reported a case of a cerebral aspergillosis who was diagnosed by brain biopsy.We therapy with in-travenous caspofungin by two 0.2 g dose/day for 70 days,and combined intermittent small doses of intrathecal injection of amphotericin B by dose of just 0.1 mg,1/week.Results A magnetic resonance imaging of the brain and a cranial CT scan were reviewed.Pathologi-cal changes were absorbed and clinical symptoms from the previous improved markedly.We reviewed follow-up of 3 years without recur-rence.Conclusion Therapy with intravenous caspofungin and combined intermittent small doses of intrathecal injection of amphotericin B has a effect therapy,and which has a low side effect.